Conflict of interest: Drs. Greenwood, Joo, Kelsoe, Remick, and Sadovnick and Ms. Shekhtman have no competing financial interests to report. Dr. McElroy is a consultant to or member of the scientific advisory board of Alkermes, Eli Lilly, Teva, and Shire and has received unrelated research support from the Agency for Healthcare Research & Quality (AHRQ), Alkermes, AstraZeneca, Bristol–Myers Squibb, Cephalon, Eli Lilly, Forest Labs, GalaxoSmith Kline, Jazz Pharmaceuticals, Marriott Foundation, Orexigen Therapeutics, Shire, and Takeda Pharmaceutical Company. Dr. McElroy is also an inventor on United States Patent No. 6,323,236 B2 for the use of sulfamate derivatives for treating impulse control disorders and has received payments from Johnson & Johnson Pharmaceutical Research and Development, which has exclusive rights under the patent. Dr. Keck is a co-inventor on a United States Patent (No. 6,387,956) for treating obsessive–compulsive spectrum disorder through tramadol and has received no financial gain.
Research Article
Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder†‡
Article first published online: 19 DEC 2012
DOI: 10.1002/ajmg.b.32108
Copyright © 2012 Wiley Periodicals, Inc.
Issue

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Volume 162, Issue 2, pages 137–145, March 2013
Additional Information
How to Cite
Greenwood, T. A., Joo, E.-J., Shekhtman, T., Sadovnick, A. D., Remick, R. A., Keck, P. E., McElroy, S. L. and Kelsoe, J. R. (2013), Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. Am. J. Med. Genet., 162: 137–145. doi: 10.1002/ajmg.b.32108
- †
- ‡
How to Cite this Article: Greenwood TA, Joo E-J, Shektman T, Sadovnick AD, Remick RA, Keck PE, McElroy SL, Kelsoe JR. 2012. Association of Dopamine Transporter Gene Variants With Childhood ADHD Features in Bipolar Disorder. Am J Med Genet Part B 162B:137–145.
Publication History
- Issue published online: 21 FEB 2013
- Article first published online: 19 DEC 2012
- Manuscript Accepted: 27 SEP 2012
- Manuscript Received: 4 JUN 2012
Funded by
- Novartis Pharma AG, Department of Veterans Affairs and the National Institute of Mental Health. Grant Number: MH47612 MH59567 MH68503 MH078151
- UCSD Mental Health Clinical Research Center. Grant Number: MH30914
- UCSD General Clinical Research Center. Grant Number: M01 RR00827
- National Institute of Mental Health. Grant Number: K01-MH087889
- National Research Foundation of Korea Grant. Grant Number: 2011-0003164
- Abstract
- Article
- References
- Cited By
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!

1552-485X/asset/olbannerleft.gif?v=1&s=0e43f7e039a24ecded43bfd7a5ca0adda740e12f)
1552-485X/asset/olbannerright.gif?v=1&s=b0c982f852f9ce2872fa6ab21687106020e0e7d3)